Newsroom - Page 2

With 1 biosimilar already approved in the US, the FDA has finally released draft guidelines for naming these new products.
The study sheds light on a potential way to reconfigure the school day to create opportunities for physical activity. More work would be needed, researchers say.
When measuring quality of pediatric care, hospitals should include different-hospital readmission along with same-hospital readmission, the authors conclude.
The approval of evolocumab (Repatha) creates competition in the new class of PCSK9 cholesterol-fighting therapies and managed care plans and pharmacy benefit managers are expected to take full advantage to hold down costs.
Published in the journal Neurology, the study identified childhood cancer, along with hypertension and age, as a risk factor for recurrent stroke.
A pathways company has followed up its medical and radiation oncology clinical decision tools with a new surgical oncology platform.
Fears of health insurance premium hikes during the third year of the Affordable Care Act may not be unfounded. In Tennessee, the state’s insurance commissioner just approved BlueCross BlueShield of Tennessee's 36.3% increase.
The use of hospital observation instead of hospital admission is becoming increasingly common for Medicare beneficiaries; however, it may mean unexpectedly higher out-of-pocket costs.